Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Transdermal System for CINV in HER2+ Breast Cancer
NCT04472143Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jul 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Granisetron Hydrochloride Nasal Spray in chemotherapy-induced nausea and vomiting (CINV), sponsored by Fudan University. Status: unknown.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04472143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04472143.